A correlation between the tyrosine phosphorylation status of Gab1 and the progression of ErbB2-transgene driven murine mammary tumours has also been reported, indicating that Gab1 needs to be considered as an important downstream effector of this oncogenic RTK as well [205]. This evidence concerns the gene ERBB2 and breast cancer.